Programa de Biología y Regeneración Oral

Medicina y ciencias biológicas

1. Mesenchymal Stem Cells 100%
2. Gingival Crevicular Fluid 99%
3. Periodontitis 94%
4. Regenerative Endodontics 75%
5. Dental Pulp 75%
6. Tooth 71%
7. Peri-Implantitis 58%
8. Periapical Periodontitis 49%
9. Dental Pulp Cavity 45%
10. Endodontics 45%
11. Biomarkers 45%
12. Platelet-Rich Fibrin 42%
13. Pulpitis 41%
14. Gestational Diabetes 41%
15. Stem Cells 39%
16. Extracellular Vesicles 36%
17. Pregnancy 32%
18. Matrix Metalloproteinase 8 30%
19. Pre-Eclampsia 29%
20. Neuropilin-1 27%
21. Case-Control Studies 24%
22. Cross-Sectional Studies 23%
23. Intercellular Signaling Peptides and Proteins 22%
24. Regeneration 22%
25. tricalcium silicate 20%
26. Cell Proliferation 20%
27. Cone-Beam Computed Tomography 20%
28. placental alkaline phosphatase 19%
29. C-Reactive Protein 19%
30. Mucositis 19%
31. Tissue Engineering 18%
32. Dentin 18%
33. Porphyromonas gingivalis 18%
34. Calcium Hydroxide 17%
35. Logistic Models 17%
36. Dentinal Fluid 17%
37. Porphyromonas endodontalis 16%
38. Periodontal Diseases 16%
39. Cell- and Tissue-Based Therapy 15%
40. MicroRNAs 15%
41. Chronic Periodontitis 15%
42. Rheumatoid Arthritis 15%
43. Biocompatible Materials 15%
44. Porphyromonas 14%
45. Dental Sac 14%
46. Dental Pulp Capping 14%
47. Treponema denticola 14%
48. Osteoprotegerin 13%
49. Blood Grouping and Crossmatching 13%
50. Therapeutics 13%
51. Dental Papilla 13%
52. Acellular Dermis 13%
53. Workflow 13%
54. Toll-Like Receptor 2 13%
55. mineral trioxide aggregate 13%
56. Enzyme-Linked Immunosorbent Assay 12%
57. Early Diagnosis 12%
58. Randomized Controlled Trials 12%
59. ROC Curve 12%
60. Ultrasonic Waves 12%
61. Bicuspid 12%
62. Placenta 12%
63. Tooth Extraction 11%
64. In Vitro Techniques 11%
65. Cell Hypoxia 11%
66. DNA 11%
67. Human Genetics 11%
68. Blood Platelets 11%
69. Phase II Clinical Trials 11%
70. Clinical Trials, Phase I 11%
71. Connective Tissue 11%
72. poly(lactide) 11%
73. Polymers 11%
74. Porosity 10%
75. Interleukin-6 10%
76. Bone and Bones 10%
77. Pregnant Women 10%
78. Molecular Pathology 10%
79. Umbilical Cord 10%
80. Pregnancy Complications 10%
81. Angiogenesis Inducing Agents 10%
82. Cell Differentiation 10%
83. Pedigree 10%
84. Controlled Clinical Trials 10%
85. Paraffin 10%
86. Matrix Metalloproteinases 10%
87. Matrix Metalloproteinase 9 9%
88. Mouth 9%
89. Formaldehyde 9%
90. Maxilla 9%
91. Chile 9%
92. Fetal Development 9%
93. Cheek 9%
94. Regulatory T-Lymphocytes 9%
95. Microbiota 9%
96. Mandible 9%
97. Type 2 Diabetes Mellitus 9%
98. High-Throughput Nucleotide Sequencing 8%
99. Systemic Lupus Erythematosus 8%
100. Chemokines 8%